BE ATC B01AD04 · updated 2 Nov 2026
Urokinase shortage in Belgium
Is there a Urokinase shortage in Belgium?
Yes. As of 2 Nov 2026, 2 Urokinase products are reported short in Belgium, the first since 12 Oct 2022. The company estimate for the return is 6 Jan 2027. Main reason: other.
Also short in France, Japan. All countries.
Affected products in Belgium
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| BE | Actosolv 600 000 IU inj./inf. sol. (pwdr.) i.v./i.arter. 600000 IU | Eumedica Pharmaceuticals | 12 Oct 2022 | 6 Jan 2027 | Other Other reason |
| BE | Actosolv 100 000 IU inj./inf. sol. (pwdr.) i.v./i.arter. 100000 IU | Eumedica Pharmaceuticals | 24 Oct 2022 | 6 Jan 2027 | Other Other reason |
Source
FAMHP (Federal Agency for Medicines and Health Products), PharmaStatus / SAMv2. Official list. All authorised packs with a declared temporary unavailability.